
| Pair Name | Curcumin, Doxorubicin | ||
| Phytochemical Name | Curcumin (PubChem CID: 969516 ) | ||
| Anticancer drug Name | Doxorubicin (PubChem CID: 31703 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Curcumin, Doxorubicin | |||
| Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
| Biological Phenomena | Inhibition-->Angiogenesis | |||
| Gene Regulation | Up-regulation | Expression | VIM | hsa7431 |
| Down-regulation | Expression | CDH1 | hsa999 | |
| Up-regulation | Expression | CASP3 | hsa836 | |
| In Vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens (Human) | CVCL_0027 |
| H22 | Hepatocellular carcinoma | Mus musculus (Mouse) | CVCL_H613 | |
| In Vivo Model | BALB/c mice were subcutaneously implanted with H22 cells at a concentration of 1×10⁶ cells per mouse.Therapeutic drugs (DOX, 3 mg/kg; CUR, 0.75 mg/kg) were injected into the mice in the treated groups (saline, DC, DOX/Pep2, DOX/Pep1, DC/Pep2, DC/Pep1) via the tail vein every other day for 14 days starting on day 6. The tumor sizes and mouse body weights were measured every other day. | |||
| Result | Our findings provide a novel and simple approach to nhibit the growth and metastasis of hepatocellular carcinoma. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Morphologically transformable peptide nanocarriers coloaded with doxorubicin and curcumin inhibit the growth and metastasis of hepatocellular carcinoma. Mater Today Bio. 2023 Dec 12;24:100903. doi: 10.1016/j.mtbio.2023.100903. | Click |